Drug Trial Radar · NCT03358576
Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)
Last checked: Nov 19, 2026Latest source record: Dec 1, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
674
Actual
Start
Sep 18, 2018
Primary completion
Oct 2, 2019
Study completion Oct 2, 2019
Sponsor
- Lead sponsor
- Iterum Therapeutics, International LimitedIndustry
- Sponsor type
- Industry
- First posted
- Nov 30, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, Phase 3, randomized, multi-center, double-blind study of the efficacy, tolerability and safety of sulopenem followed by sulopenem-etzadroxil/probenecid versus ertapenem followed by ciprofloxacin-metronidazole for treatment of complicated intra-abdominal infections in adults.
Conditions
- Intra Abdominal Infections
Interventions
ErtapenemDrug
Antibiotic for complicated intra-abdominal infection
Sulopenem-Etzadroxil/ProbenecidDrug
Antibiotic for complicated intra-abdominal infection
CiprofloxacinDrug
Antibiotic for complicated intra-abdominal infection
MetronidazoleDrug
Antibiotic for complicated intra-abdominal infection
Amoxicillin-ClavulanateDrug
Antibiotic for complicated intra-abdominal infection
SulopenemDrug
Antibiotic for complicated intra-abdominal infection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Clinical SuccessTime frame: Day 28 +/- 1 day
Locations
42 sites in 7 countries. Site status is shown where the registry gives one.
Medical Facility
Chula Vista, California
Medical Facility
Torrance, California
Medical Facility
Idaho Falls, Idaho
Medical Facility
Boston, Massachusetts
Medical Facility
Royal Oak, Michigan
Medical Facility
St Louis, Missouri
Medical Facility
Butte, Montana
Medical Facility
Lincoln, Nebraska
Medical Facility
Omaha, Nebraska
Medical Facility
Somers Point, New Jersey
Medical Facility
Columbus, Ohio
Medical Facility
Columbus, Ohio
Medical Facility
Blagoevgrad, Bulgaria
Medical Facility
Lom, Bulgaria
Medical Facility
Pleven, Bulgaria
Medical Facility
Plovdiv, Bulgaria
Medical Facility
Plovdiv, Bulgaria
Medical Facility
Rousse, Bulgaria
Medical Facility
Sofia, Bulgaria
Medical Facility
Varna, Bulgaria
Medical Facility
Varna, Bulgaria
Medical Facility
Kohtla-Järve, Estonia
Medical Facility
Tallinn, Estonia
Medical Facility
Tallinn, Estonia
Medical Facility
Tartu, Estonia
Medical Facility
Viljandi, Estonia
Medical Facility
Võru, Estonia
Medical Facility
Gori, Georgia
Medical Facility
Kutaisi, Georgia
Medical Facility
Tbilisi, Georgia
Medical Facility
Tbilisi, Georgia
Medical Facility
Tbilisi, Georgia
Medical Facility
Tbilisi, Georgia
Medical Facility
Tbilisi, Georgia
Medical Facility
Tbilisi, Georgia
Medical Facility
Kaposvár, Hungary
Medical Facility
Pécs, Hungary
Medical Facility
Veszprém, Hungary
Medical Facility
Daugavpils, Latvia
Medical Facility
Rēzekne, Latvia
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.